Overview Three recent congressional proposals — the 340B for Patients Act, the SECURE 340B Act, and the SUSTAIN 340B Act — seek to make comprehensive changes to the current structure of the 340B Drug Pricing Program. Each proposal takes a unique approach to addressing critical components of…
340B Drug Pricing Program
As policymakers continue to discuss healthcare legislation, the AHA has developed several new resources to help hospitals and other stakeholders understand the proposals and their potential impact.
The Health Resources and Services Administration’s Office of Pharmacy Affairs Sept. 8 released information on the 340B Office of Pharmacy Affairs Information System Paperwork Reduction Act forms.
Several states have enacted laws protecting 340B contract pharmacy arrangements by requiring drug manufacturers to honor discounted pricing at those locations to preserve patient access. Manufacturers have challenged these laws in courts nationwide. This webpage compiles decisions in those cases as…
The Centers for Medicare & Medicaid Services has released a fact sheet and FAQs on the 340B Part D claims data repository that will go live Oct. 1.
The AHA Aug. 26 urged the Centers for Medicare & Medicaid Services not to finalize two proposals in the calendar year 2027 outpatient prospective payment system proposed rule, warning that the policies suffer from “serious legal defects and substantial policy shortcomings” and would place…
The AHA Aug. 26 urged the Centers for Medicare & Medicaid Services not to finalize two proposals in the calendar year 2027 outpatient prospective payment system proposed rule,
AHA comments on two aspects of the Centers for Medicare & Medicaid Services’ (CMS) 2027 Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems Rule.
The AHA Aug. 25 submitted comments to Sen. Bill Cassidy, R-La., on the 340B Drug Pricing Integrity and Affordability for Patients Act (340B for Patients Act), a legislative discussion draft that would make significant changes to the current structure and scope of the 340B program.
AHA provides feedback on the 340B Drug Pricing Integrity and Affordability for Patients Act (340B for Patients Act) discussion draft.